Anders Vikstrom

Linkoeping, E, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 18, 2024

Earlier detection of lung cancer through analysis of circulating tumor DNA from blood

Earlier detection of lung cancer through analysis of circulating tumor DNA from blood

Journal: Lakartidningen

Published: May 07, 2024

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Journal: International journal of molecular sciences

Published: February 26, 2024

First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy.

First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 10, 2023

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.

ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.

Journal: Frontiers in oncology

Published: August 22, 2023

Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer.

Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer.

Journal: The oncologist

Published: March 31, 2023

KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry.

KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry.

Journal: Clinical lung cancer

Published: February 21, 2023

Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration - a Swedish nationwide retrospective study.

Use of ALK-tyrosine kinase inhibitors (ALK TKI) in clinical practice, overall survival, and treatment duration - a Swedish nationwide retrospective study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 11, 2022

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.

Real-world experience with capmatinib in MET exon 14-mutated non-small cell lung cancer (RECAP): a retrospective analysis from an early access program.

Journal: Therapeutic advances in medical oncology

Published: January 16, 2022

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program.

Journal: Therapeutic advances in medical oncology

Published: April 09, 2021

A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.

A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.

Journal: International journal of cancer

Published: March 25, 2020

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.

Journal: Scientific reports

Published: October 24, 2018

Showing 1-12 of 21

Last Updated: 09/26/2026